• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings

Fidelity® Low Volatility Factor ETF FDLO

Last Price$27.78Day Change (%)0.04%
Open Price$27.81Day Change ($)0.01
Day Range27.74–27.8152-Week Range24.30–27.81

As of Fri 5/26/2017 4:58:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast 2017-2023: Focus on Product Type, Test Type, Application, and Competitive Landscape - Research and Markets

    Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast 2017-2023: Focus on Product Type, Test Type, Application, and Competitive Landscape - Research and Markets

  2. Contract Research Outsourcing Report 2017 - Analysis By Drug Discovery, Preclinical Research & Clinical Research - Research and Markets

    Contract Research Outsourcing Report 2017 - Analysis By Drug Discovery, Preclinical Research & Clinical Research - Research and Markets

  3. LabCorp Completes Acquisition of Pathology Associates Medical Laboratories

    LabCorp Completes Acquisition of Pathology Associates Medical Laboratories

  4. Global Kidney Function Tests (Dilution & Concentration, Clearance, Urine, Imaging Tests) Market Analysis And Segment Forecasts, 2014 - 2025 - Research and Markets

    Global Kidney Function Tests (Dilution & Concentration, Clearance, Urine, Imaging Tests) Market Analysis And Segment Forecasts, 2014 - 2025 - Research and Markets

  5. The Future of Health Care: The Prognosis Is Optimistic

    LabCorp LH has announced that its long-standing CEO Thomas Mac Mahon will retire at the end of 2006 and will be replaced by COO David King. To facilitate a smooth transition, Mac Mahon will provide consulting services to the company and remain chairman until May 2008. This transition has no impact ...

  6. A Smoother (But Still Bumpy) Emerging Markets Ride

    Low-volatility emerging-markets ETF can reduce risk and still provide diversification benefits investors seek.

  7. Health Care’s Latest Prognosis

    Amid a pullback, health-care companies are preparing for the next phase of the Affordable Care Act.

©2017 Morningstar Advisor. All right reserved.